Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis

被引：0
|
作者：
Silverberg, J. I. [1 ]
Barbarot, S. [2 ]
Gooderham, M. [3 ]
Simon, J. C. [4 ]
Simpson, E. [5 ]
Kurbasic, A. [6 ]
Olsen, C. K. [6 ]
Cork, M. J. [7 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA
[2] CHU Nantes, Dept Dermatol, Nantes, France
[3] SKiN Ctr Dermatol, Peterborough, ON, Canada
[4] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Leipzig, Germany
[5] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[6] LEO Pharma AS, Ballerup, Denmark
[7] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
342
引用
收藏
页码：E64 / E65
页数：2
相关论文
共 50 条
  • [31] Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis (AD): Analysis of a Phase 2b, randomized, double-blind, placebo-controlled study (NCT02347176)
    Wollenberg, A.
    Guttman-Yassky, E.
    Torpet, M.
    Silverberg, J. I.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 40 - 41
  • [32] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [33] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [34] Efficacy and safety of itopride in functional dyspepsia: Results of two phase III multicentre, randomized, double-blind, placebo-controlled trials
    Talley, Nicholas J.
    Tack, Jan
    Ptak, Theadore
    Gupta, Rajendra
    Giguere, Monique
    GASTROENTEROLOGY, 2007, 132 (04) : A93 - A93
  • [35] DUPILUMAB TREATMENT IN PATIENTS WITH ATOPIC HAND AND FOOT DERMATITIS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Worm, Margitta
    Honari, Golara
    Masuda, Koji
    Schuttelaar, Marie-Louise A.
    Maloney, Jennifer
    Xiao, Jing
    Dubost-Brama, Ariane
    Bansal, Ashish
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 53 - 54
  • [36] Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, Eric L.
    Silverberg, Jonathan, I
    Worm, Margitta
    Honari, Golara
    Masuda, Koji
    Sygula, Ewa
    Maloney, Jennifer
    Mannent, Leda P.
    Xiao, Jing
    Dubost-Brama, Ariane
    Bansal, Ashish
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [37] Dupilumab treatment in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, E.
    Silverberg, J.
    Worm, M.
    Honari, G.
    Masuda, K.
    Sygula, E.
    Maloney, J.
    Mannent, L.
    Xiao, J.
    Dubost-Brama, A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S350 - S350
  • [38] Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)
    Blauvelt, Andrew
    Wollenberg, Andreas
    Pink, Andrew
    Peris, Ketty
    Gemelli, A.
    Armstrong, April
    Spelman, Lynda
    Saeki, Hidehisa
    Lynde, Charles
    Herranz, Pedro
    Barbarot, Sebastien
    Simpson, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB177 - AB177
  • [39] <show/>Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials<show/>
    Yosipovitch, Gil
    Lio, Peter A.
    Rosmarin, David
    Serra-Baldrich, Esther
    Legat, Franz J.
    Casillas, Marta
    Pierce, Evangeline
    Liu, Zhuqing
    Sun, Luna
    Elmaraghy, Hany
    Staender, Sonja
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (02) : 289 - 291
  • [40] Fluoxetine (SSRI) treatment of canine atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover trial
    Fujimura, M.
    Ishimaru, H.
    Nakatsuji, Y.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2014, 17 (02): : 371 - 373
12345